| Presented by: | The American Society of Health-System Pharmacists |
| Lecturer | Joseph Saseen, Pharm.D., FCCP, BCPS, CLS and Carrie M. Maffeo, Pharm.D., BCPS, CDE |
| Approximate duration: | 1 hr. |
| Summary points: | In this audiovisual CME programme, 2 clinical pharmacy experts discuss the clinical and economic impact of coronary heart disease (CHD), obesity, mixed dyslipidemia, and metabolic syndrome in the United States. They also use case studies to illustrate the decision-making process for patients at risk for CHD because of obesity or mixed dyslipidemia. |
| Accreditation: | The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The program provides 1 hour (0.10 CEU) of continuing education credit (program number 204-000-08-469-H01-P).
Expiration Date: February 28, 2010. |
| Other: | |
E-Mail this webcast/CME to a colleague
The Evolution of Cardiometabolic Risk Reduction and Mixed Dyslipidemia: Examining the Role of Chronic Obesity Management
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
